High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma

Raschle, J; Ratschiller, D; Mans, S; Mueller, B U; Pabst, T (2011). High levels of circulating CD34+ cells at autologous stem cell collection are associated with favourable prognosis in multiple myeloma. British journal of cancer, 105(7), pp. 970-4. Basingstoke: Nature Publishing Group 10.1038/bjc.2011.329

Full text not available from this repository. (Request a copy)

High-dose chemotherapy with autologous stem cell transplantation is a cornerstone in the first-line treatment of multiple myeloma patients. However, only few factors have been identified affecting the outcome in such patients. We hypothesised that varying levels of mobilised CD34+ cells confer prognostic information in myeloma patients undergoing high-dose chemotherapy.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Pabst, Thomas Niklaus

ISSN:

0007-0920

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:20

Last Modified:

02 Mar 2023 23:20

Publisher DOI:

10.1038/bjc.2011.329

PubMed ID:

21878938

Web of Science ID:

000295357900015

URI:

https://boris.unibe.ch/id/eprint/6464 (FactScience: 211430)

Actions (login required)

Edit item Edit item
Provide Feedback